Pt Kalbe Farma Tbk Stock Price, News & Analysis

PTKFY OTC

Company Description

PT KALBA FARMA UNSP/ADR (PTKFY) is a pharmaceutical company based in Indonesia, focusing on the development and distribution of a wide range of healthcare products. With a strong emphasis on research and innovation, the company has been at the forefront of introducing novel treatments and medications to improve the quality of life for patients. Their commitment to quality and patient care has earned them a stellar reputation in the industry.

PT KALBA FARMA UNSP/ADR is known for its diverse portfolio of pharmaceutical products catering to various therapeutic areas, including cardiovascular health, oncology, and infectious diseases. The company's efforts in forging strategic partnerships and collaborations have further enhanced its market presence and global reach. With a solid financial standing and a dedicated team of professionals, PT KALBA FARMA UNSP/ADR continues to drive innovation and excellence in the pharmaceutical sector.

Stock Performance

Chart

$18.65

+7.77%

+1.34

Last updated: July 1, 2025 at 14:04

- %

Performance 1 year

$2.9B

Market Cap

228.2M

Shares outstanding

Latest News

View All

October 23, 2023

0.00%

Genexine and KGbio received the first market approval for novel long-acting Erythropoietin, Efepoetin alfa, from The Indonesian Food and Drug Authority (BPOM)

SEC Filings

View All

No SEC filings available for Pt Kalbe Farma Tbk.

Financial Highlights

—

Revenue (TTM)

—

Net Income (TTM)

—

Diluted EPS (TTM)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Frequently Asked Questions

What is the current stock price of Pt Kalbe Farma Tbk (PTKFY)?

The current stock price of Pt Kalbe Farma Tbk (PTKFY) is $18.65 as of July 1, 2025.

What is the market cap of Pt Kalbe Farma Tbk (PTKFY)?

The market cap of Pt Kalbe Farma Tbk (PTKFY) is approximately 2.9B.

What is PT KALBA FARMA UNSP/ADR known for?

PT KALBA FARMA UNSP/ADR is known for its wide range of healthcare products and its focus on research and innovation in the pharmaceutical sector.

In which country is PT KALBA FARMA UNSP/ADR based?

PT KALBA FARMA UNSP/ADR is based in Indonesia.

What therapeutic areas does PT KALBA FARMA UNSP/ADR cater to?

PT KALBA FARMA UNSP/ADR caters to therapeutic areas including cardiovascular health, oncology, and infectious diseases.

What sets PT KALBA FARMA UNSP/ADR apart from other pharmaceutical companies?

PT KALBA FARMA UNSP/ADR stands out for its commitment to quality, patient care, and innovation, along with its strong market presence and global reach.

How does PT KALBA FARMA UNSP/ADR contribute to the healthcare industry?

PT KALBA FARMA UNSP/ADR contributes to the healthcare industry by introducing novel treatments and medications to improve patient outcomes.

What is the financial standing of PT KALBA FARMA UNSP/ADR?

PT KALBA FARMA UNSP/ADR has a solid financial standing, reflecting its stability and growth potential in the pharmaceutical sector.

What type of collaborations has PT KALBA FARMA UNSP/ADR engaged in?

PT KALBA FARMA UNSP/ADR has engaged in strategic partnerships and collaborations to enhance its market presence and global reach.

How does PT KALBA FARMA UNSP/ADR drive innovation in the pharmaceutical sector?

PT KALBA FARMA UNSP/ADR drives innovation through its dedicated team of professionals and its focus on research and development.

What is the reputation of PT KALBA FARMA UNSP/ADR in the industry?

PT KALBA FARMA UNSP/ADR has earned a stellar reputation in the pharmaceutical industry for its quality products and commitment to patient care.

What can investors expect from PT KALBA FARMA UNSP/ADR?

Investors can expect continued innovation and excellence from PT KALBA FARMA UNSP/ADR, backed by its strong market presence and financial stability.